MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-14-2026
Pulse Biosciences P/CF Ratio 2011-2026 | PLSE
Annual P/CF Ratio Pulse Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -31.5 | -40.6 | -13.1 | -2.04 | -6.29 | -22.4 | -8.7 | -9.12 | -22.2 | -8.45 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.04 | -40.6 | -16.4 |
P/CF Ratio of other stocks in the Medical instruments industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ICU Medical
ICUI
|
20.4 | $ 128.04 | 3.54 % | $ 3.15 B |  USA |
 |
Atrion Corporation
ATRI
|
32 K | - | - | $ 810 M | USA |
 |
The Cooper Companies
COO
|
20.5 | $ 62.04 | 0.95 % | $ 12.4 B | USA |
 |
Intuitive Surgical
ISRG
|
56.4 | $ 449.6 | 1.82 % | $ 160 B | USA |
 |
Luminex Corporation
LMNX
|
39.6 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-0.0678 | - | -9.52 % | $ 20.6 M | USA |
 |
Repro Med Systems
KRMD
|
431 | $ 4.02 | 1.52 % | $ 186 M | USA |
 |
Alcon
ALC
|
31.6 | $ 67.45 | 1.77 % | $ 40.4 B |  Schweiz |
 |
LeMaitre Vascular
LMAT
|
31.2 | $ 101.59 | 0.26 % | $ 2.3 B | USA |
 |
iRhythm Technologies
IRTC
|
62.8 | $ 116.68 | 2.49 % | $ 3.73 B | USA |
 |
Masimo Corporation
MASI
|
45.6 | $ 178.83 | 0.02 % | $ 9.53 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
108 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
22.1 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
4.24 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
16.1 | - | -0.05 % | $ 10.3 B | USA |
 |
Milestone Scientific
MLSS
|
-8.16 | $ 0.39 | 12.88 % | $ 32 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
-2.21 | - | - | $ 28.6 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
22.2 | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
-0.0068 | $ 6.1 | 3.3 % | $ 51.7 K | USA |
 |
Envista Holdings Corporation
NVST
|
17.5 | $ 23.66 | 2.62 % | $ 3.97 B | USA |
 |
Haemonetics Corporation
HAE
|
16.9 | $ 59.25 | 4.22 % | $ 2.98 B | USA |
 |
STERIS plc
STE
|
21 | $ 215.44 | 0.48 % | $ 21.2 B | USA |
 |
Isoray
ISR
|
-1.34 | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
-74.5 | $ 145.13 | 3.73 % | $ 7.03 B | USA |
 |
STAAR Surgical Company
STAA
|
-27.5 | $ 33.16 | 1.72 % | $ 1.64 B | USA |
 |
Utah Medical Products
UTMD
|
13.6 | $ 63.67 | -0.52 % | $ 206 M | USA |
 |
InfuSystem Holdings
INFU
|
4.81 | $ 10.11 | 4.55 % | $ 209 M | USA |
 |
Microbot Medical
MBOT
|
-9.2 | $ 1.74 | 0.29 % | $ 79.7 M |  Israel |
 |
Teleflex Incorporated
TFX
|
52.2 | $ 134.63 | 1.39 % | $ 6.01 B | USA |
 |
Merit Medical Systems
MMSI
|
16.3 | $ 64.27 | 0.78 % | $ 3.8 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
10.7 | $ 9.87 | 1.28 % | $ 1.97 B | USA |
 |
West Pharmaceutical Services
WST
|
23.3 | $ 305.58 | 0.54 % | $ 22.1 B | USA |
 |
Retractable Technologies
RVP
|
-2.84 | $ 0.67 | -1.32 % | $ 20.1 M | USA |
 |
Pro-Dex
PDEX
|
-89.4 | $ 63.35 | 4.23 % | $ 208 M | USA |
 |
Predictive Oncology
POAI
|
-0.776 | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
49.1 | $ 24.09 | 4.51 % | $ 1.15 B | USA |
 |
Stereotaxis
STXS
|
-12.5 | $ 1.84 | 6.07 % | $ 167 M | USA |
 |
Baxter International
BAX
|
11.4 | $ 18.73 | 2.15 % | $ 9.61 B | USA |
 |
ResMed
RMD
|
99.8 | $ 211.1 | 1.6 % | $ 30.8 B | USA |
 |
AtriCure
ATRC
|
27.2 | $ 28.96 | 0.56 % | $ 1.38 B | USA |
 |
Harvard Bioscience
HBIO
|
3.1 | $ 5.27 | 5.09 % | $ 234 M | USA |
 |
NeuroMetrix
NURO
|
-1.22 | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
-35.1 | $ 11.79 | 3.06 % | $ 482 M | USA |
 |
Becton, Dickinson and Company
BDX
|
29.1 | $ 146.54 | -0.28 % | $ 42.2 B | USA |
 |
Nephros
NEPH
|
20.2 | $ 3.56 | -1.93 % | $ 37.8 M | USA |
 |
OraSure Technologies
OSUR
|
-4.8 | $ 3.11 | 0.81 % | $ 229 M | USA |
 |
Repligen Corporation
RGEN
|
0.0568 | $ 111.06 | 2.34 % | $ 6.25 M | USA |